Plymouth Lane Capital Management Exits Position in Teladoc Inc (TDOC)

Teladoc Inc (TDOC) : Plymouth Lane Capital Management has sold out all of its stake in Teladoc Inc during the most recent quarter, according to the disclosure filed by the company on Aug 11, 2016 with the SEC. The investment management company has sold out 60,000 shares of Teladoc Inc which is valued at $1,053,600.

Other Hedge Funds, Including , Tiaa Cref Investment Management boosted its stake in TDOC in the latest quarter, The investment management firm added 36,816 additional shares and now holds a total of 65,938 shares of Teladoc Inc which is valued at $1,157,871.Blackrock Institutional Trust Company N.a. boosted its stake in TDOC in the latest quarter, The investment management firm added 93,420 additional shares and now holds a total of 321,924 shares of Teladoc Inc which is valued at $5,652,985.Teacher Retirement System Of Texas boosted its stake in TDOC in the latest quarter, The investment management firm added 294 additional shares and now holds a total of 2,415 shares of Teladoc Inc which is valued at $39,509. Aberdeen Asset Management Plcuk sold out all of its stake in TDOC during the most recent quarter. The investment firm sold 14,136 shares of TDOC which is valued $251,197.

Teladoc Inc opened for trading at $18.07 and hit $18.3 on the upside on Tuesday, eventually ending the session at $18, with a gain of 0.11% or 0.02 points. The heightened volatility saw the trading volume jump to 1,95,891 shares. Company has a market cap of $823 M.

On the company’s financial health, Teladoc Inc reported $-0.38 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 3, 2016. Analyst had a consensus of $-0.39. The company had revenue of $26.49 million for the quarter, compared to analysts expectations of $28.20 million. The company’s revenue was up 44.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.46 EPS.

Many Wall Street Analysts have commented on Teladoc Inc. Shares were Reiterated by Deutsche Bank on Aug 4, 2016 to “Buy” and Lowered the Price Target to $ 20 from a previous price target of $21 .Shares were Reiterated by FBR Capital on Aug 4, 2016 to “Outperform” and Lowered the Price Target to $ 28 from a previous price target of $34 .Shares were Reiterated by FBR Capital on Jul 20, 2016 to “Outperform” and Lowered the Price Target to $ 34 from a previous price target of $36 .

Teladoc Inc. is a telehealth company. The Company offers an on-demand healthcare platform through mobile devices Internet video and phone. Its solution connects consumers with physicians and behavioral health professionals or its providers who treat various conditions and cases from acute diagnoses such as upper respiratory infection urinary tract infection and sinusitis to dermatological conditions anxiety and smoking cessation. The Teladoc solution enables accessing on-demand healthcare for employers health plans and health systems. Its platform provides accessing physicians clinical programs and consumer engagement strategies. Its platform provides for interconnectivity between healthcare constituents. It offers solutions such as remote patient monitoring post-discharge treatment plan adherence and in-home and chronic care. Its customers also include channel partners such as brokers resellers and consultants who sell into a range of small medium and large enterprises.

Leave a Reply

Teladoc Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Teladoc Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.